Skip to search formSkip to main contentSkip to account menu

AN 132

Known as: AN-132 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
AN-132 block of cardiac sodium channels: A gate-related receptor analysis
SummaryBased on the gate-related receptor hypothesis, an analysis of kinetics of AN-132, a new antiarrhythmic agent, blockade of… 
2004
2004
Effects of AN-132, a novel antiarrhythmic lidocaine analogue, and of lidocaine on membrane ionic currents of guinea-pig ventricular myocytes
SummaryWe studied the effects of AN-132 (10, 30 and 100 μmol/1), an analogue of lidocaine, on membrane currents and action… 
1990
1990
Two types of sodium channel block by class-I antiarrhythmic drugs studied by using Vmax of action potential in single ventricular myocytes.
1990
1990
Electrophysiological Effects of AN‐132, a New Antiarrhythmic Compound, in Guinea Pig Papillary Muscles
We used electrophysiological techniques to examine the effects of AN-132, a new antiarrhythmic agent, on transmembrane action… 
1989
1989
Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles
SummaryUsing two-stage coronary-ligation-, digitalis-and adrenaline-induced ventricular arrhythmias in beagles, antiarrhythmic… 
1989
1989
AN-132, a new class I anti-arrhythmic agent, depresses the acetylcholine-induced K+ current in atrial myocytes.
1989
1989
Electrophysiological effects of the new antiarrhythmic drug 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide++ + on dog cardiac muscle.
The effects of 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide (AN-132), a new antiarrhythmic drug, on the electrical… 
1988
1988
Frequency and voltage dependent effects of AN-132, a new class I anti-arrhythmic agent, on Vmax of action potential upstroke in guinea pig ventricular muscles.
The in vitro electrophysiological properties of a newly synthesised antiarrhythmic agent, AN-132, were evaluated by recording… 
1988
1988
Cardiovascular profile of AN-132, a new diamine derivative antiarrhythmic agent, revealed in the isolated, blood-perfused dog heart.
The cardiac and coronary effects of AN-132, a new antiarrhythmic agent, were investigated in isolated, blood-perfused… 
1987
1987
Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
The antiarrhythmic activities of AN-132, 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide X 2H3PO4, compared with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)